Detalhe da pesquisa
1.
Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 95(5): 410-418, 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37940409
2.
Effect of resistance exercise training on plasma neurofilaments in multiple sclerosis: a proof of concept for future designs.
Neurol Sci
; 44(11): 3997-4000, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37335403
3.
Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial.
Proc Natl Acad Sci U S A
; 116(17): 8463-8470, 2019 04 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30962374
4.
CLIPPERS and its mimics: evaluation of new criteria for the diagnosis of CLIPPERS.
J Neurol Neurosurg Psychiatry
; 90(9): 1027-1038, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31072955
5.
Pumping up the Fight against Multiple Sclerosis: The Effects of High-Intensity Resistance Training on Functional Capacity, Muscle Mass, and Axonal Damage.
Healthcare (Basel)
; 12(8)2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38667599
6.
Effectiveness and Safety of Teriflunomide in Relapsing-Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study.
Neurol Ther
; 12(6): 2177-2193, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37861931
7.
OCT Variability Prevents Their Use as Robust Biomarkers in Multiple Sclerosis.
Clin Ophthalmol
; 15: 2025-2036, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34025119
8.
Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease.
Neurology
; 2021 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34380749
9.
A Pilot Study to Explore Patient Satisfaction With a Virtual Rehabilitation Program in Multiple Sclerosis: The RehabVR Study Protocol.
Front Neurol
; 11: 900, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33162924
10.
Clinical manifestations of the anti-IgLON5 disease.
Neurology
; 88(18): 1736-1743, 2017 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28381508
11.
Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes.
J Neurol
; 263(7): 1349-60, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27147513
12.
Interferon beta in relapsing-remitting multiple sclerosis. An eight years experience in a specialist multiple sclerosis centre.
J Neurol
; 252(7): 795-800, 2005 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-15772741
13.
[Long-term effect of neutralizing antibodies to interferon beta-1 b in patients with multiple sclerosis]. / Efecto a largo plazo de los anticuerpos neutralizantes de interferón beta-1 b en pacientes con esclerosis múltiple.
Med Clin (Barc)
; 124(4): 140-1, 2005 Feb 05.
Artigo
em Espanhol
| MEDLINE | ID: mdl-15713243
14.
Improvement of fatigue in multiple sclerosis by physical exercise is associated to modulation of systemic interferon response.
J Neuroimmunol
; 280: 8-11, 2015 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25773148
15.
Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (III).
Rev Neurol
; 57(7): 317-29, 2013 Oct 01.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-24052443
16.
Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I).
Rev Neurol
; 57(5): 217-29, 2013 Sep 01.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-23975528
17.
Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II).
Rev Neurol
; 54(12): 734-49, 2012 Jun 16.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-22673950
18.
Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I).
Rev Neurol
; 54(11): 677-91, 2012 Jun 01.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-22627749
19.
Interferon ß-1b for the treatment of primary progressive multiple sclerosis: five-year clinical trial follow-up.
Arch Neurol
; 68(11): 1421-7, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22084124
20.
Fatigue in progressive multiple sclerosis is associated with low levels of dehydroepiandrosterone.
Mult Scler
; 12(4): 487-94, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16900763